<DOC>
	<DOCNO>NCT00375570</DOCNO>
	<brief_summary>The Purpose study evaluate safety ME-609 treatment recurrent herpes labialis adolescent .</brief_summary>
	<brief_title>Safety Study ME-609 Treatment Herpes Simplex Labialis Adolescents</brief_title>
	<detailed_description>The objective study evaluate safety ME-609 treatment herpes labialis recurrence immunocompetent adolescent , 12 - 17 year age , follow 5-day treatment 5-time daily topical administration .</detailed_description>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Herpes Labialis</mesh_term>
	<criteria>General good health History recurrent herpes labialis two recurrence last twelve month Treatment systemic topical antiviral agent steroid within two week prior inclusion Significant skin condition occur area herpes recurrence Nursing or/and pregnancy Immunosupressed state due underlie disease ( e.g . HIV infection concomitant treatment ( e.g . cancer chemotherapy )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>